ERC Einstein Rockefeller CUNY Center for AIDS Research

ERC 爱因斯坦洛克菲勒纽约市立大学艾滋病研究中心

• 批准号: 10458261
• 负责人: Vinayaka R. Prasad
• 金额: $ 175.11万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-05-01 至 2027-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10458261
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Administrative Supplement; Applications Grants; Award; Catalytic Domain; Clinical; Clinical Sciences; Clinical and Translational Science Awards; Collaborations; Communication; Communities; Consultations; Custom; Data; Development; Epidemic; Faculty; Feedback; Foxes; Funding; Goals; Grant; Growth; HIV; Hepatitis C virus; Individual; Institution; Investments; Learning; Manuscripts; Mental Health; Mentors; Monitor; New York City; Paper; Participant; Pathway interactions; Peer Review; Pilot Projects; Privatization; Process; Publications; Publishing; Research; Research Personnel; Research Priority; Research Project Grants; Sampling; Series; Services; Simplexvirus; Structure; Study Section; Teacher Professional Development; Translational Research; Underrepresented Minority; United States National Institutes of Health; Virus; Work; career; cohort; design; experience; innovation; interest; meetings; member; peer coaching; programs; recruit; skills; success; symposium; virology; virtual

PROJECT SUMMARY ERC-CFAR: DEVELOPMENTAL CORE The Einstein-Rockefeller-CUNY CFAR (ERC-CFAR) Developmental Core will strive to provide wide-ranging support to nurture and advance the HIV/AIDS research careers of tomorrow’s HIV/AIDS researchers. Our coordinated strategy for this renewal application will be implemented via three specific aims that are centered around early stage investigators (ESIs). In Aim 1, we will employ a multi-faceted mentoring process, which combines individually tailored mentoring plans developed for each ESI and multiple forums to enable ESIs to present their HIV/AIDS research progress to the ERC-CFAR community to garner feedback and develop new collaborations. In Aim 2, we will provide ESIs with opportunities to compete in the peer-reviewed ERC-CFAR catalytic pilot grants and microgrants programs or NIH CFAR administrative supplements opportunities. Aim 3 includes dual goals of enhancing trans- and intra-institutional collaborations and scientific communication. Collaborations will be increased by: (i) recruiting non-AIDS researchers to collaborate with CFAR investigators and by removing obstacles to succeed – both by providing microgrants up to $10K and access to HIV cohorts; (ii) organizing bi-annual virtual K-clubs that are attended by ESIs from Einstein, Rockefeller and CUNY and that include both presentations by successful ESIs and by the ERC-CFAR Developmental and Operational Core leaders about all available CFAR services that can assist ESIs in their research projects and planned grant submissions; and (iii) organizing bi-annual New York City-wide research symposia attended by all NYC HIV/AIDS researchers where individuals from the different major NYC institutions will be selected to present their cutting edge research. We will enhance scientific communication among the investigators of ERC-CFAR via (i) bi-weekly Trans-institutional ERC-CFAR virtual research seminars and biweekly Clinical AIDS Center/ERC-CFAR Grand Rounds; (ii) ERC-CFAR Invited Speaker Seminars; (iii) Monthly Virus Hub meetings consisting of 13 Einstein virologists, which includes 9 faculty members that are focused on research on HIV, HSV or HCV. This provides a special one-stop-shop for all ERC-CFAR ESIs to learn about the latest virological research going on at Einstein. The impressive impact of these highly coordinated and proactive mentoring services by the ERC-CFAR Developmental Core over the past 4 years of funding is demonstrated by accomplishments of our mentored ESIs that include $20.5 million of external grants and 250 publications. The high impact of the ERC-CFAR Developmental Core’s catalytic pilot grant program, which has awarded 14 pilot grants to ESIs so far (0.46 million) from all three participant institutions, is reflected in the fact that they have already garnered up to ~$8.1 million in NIH grants (a return on investment of 17.6) and that they have published over 70 papers.

项目摘要 ERC-CFAR：发展核心 爱因斯坦 - 罗克菲勒 - 纽约CFAR（ERC-CFAR）的发育核心将努力提供大范围 支持护士和推进明天的艾滋病毒/艾滋病研究人员的艾滋病毒/艾滋病研究职业。我们的 该更新申请的协调策略将通过以下三个特定目标实施 在早期调查人员（ESI）附近。在AIM 1中，我们将采用一个多方面的心理过程， 结合了针对每个ESI制定的单独量身定制的心理计划和多个论坛，以使ESIS能够 向ERC-CFAR社区介绍他们的艾滋病毒/艾滋病研究进度，以获得反馈并开发新的反馈 协作。在AIM 2中，我们将为ESI提供机会参加同行评审的ERC-CFAR 催化飞行员赠款和微电磁计划或NIH CFAR行政补品的机会。目标3 包括增强跨机构和机构内部合作和科学沟通的双重目标。 合作将通过：（i）招募非辅助研究人员与CFAR调查人员合作 并通过消除成功的障碍 - 既可以提供高达1万美元的微型货物，又可以使用艾滋病毒队列； （ii）组织的每两年虚拟K-clubs，来自爱因斯坦，洛克菲勒和cuny的Esis参加 包括成功ESI的演示以及ERC-CFAR的发展和操作核心 领导者介绍所有可用的CFAR服务，这些服务可以帮助ESIS进行研究项目并计划赠款 提交； （iii）组织全纽约艾滋病毒/艾滋病参加的纽约市每两年的研究研讨会 选择来自不同主要纽约市不同机构的个人来介绍其切割的研究人员 边缘研究。我们将通过（i）每两周加强ERC-CFAR研究人员之间的科学沟通 跨机构的ERC-CFAR虚拟研究半货形和双周临床艾滋病中心/ERC-CFAR Grand 回合； （ii）ERC-CFAR邀请演讲者研讨会； （iii）每月病毒集线器会议由13个爱因斯坦组成 病毒学家，其中包括9名专注于HIV，HSV或HCV研究的教职员工。这提供了 所有ERC-CFAR ESI的特殊一站式车间，可了解爱因斯坦正在进行的最新病毒学研究。 ERC-CFAR对这些高度协调和积极主动的心理服务的令人印象深刻的影响 在过去的四年中，发展核心的资金由我们的指导ESI的成就证明了 其中包括2050万美元的外部赠款和250个出版物。 ERC-CFAR的高影响 Development Core的催化飞行员赠款计划，该计划已授予ESIS的14个飞行员赠款（0.46 百万）来自所有三个参与者机构，反映出他们已经获得了约8.1美元的收获。 NIH赠款（17.6的投资回报率），他们发表了70多篇论文。